Perrigo, Boehringer Ingelheim, Bayer AG and Sanofi said to be interested in acquiring Omega Pharma
Ireland's Perrigo, manufacturer of private label over-the-counter pharmaceuticals and Germany's pharmaceutical company Boehringer Ingelheim GmbH is said to be interested in acquiring Omega Pharma, the Belgian OTC medicines group, according to a newswire report, citing sources familiar with the matter.
According to the Bloomberg article, Bayer AG, the German pharmaceutical company, and France's pharmaceutical group Sanofi are also said to be interested. Morgan Stanley is advising on the deal, the item noted.
The sale could fetch up to EUR 4bn.
Perrigo, Sanofi (SAN), Boehringer and Bayer as well as Morgan Stanley declined to comment on the rumours. Omega Pharma did not respond to enquiries either.
Omega Pharma, held by the founder Marc Coucke and the private equity Waterland, reported 1H2014 operating profits of EUR 130.1m, up 60% from results in the same period in 2013.